The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, vial



Fresenius Kabi Deutschland GmbHPA2059/055/004

Main Information

Trade NamePropofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, vial
Active SubstancesPropofol
Dosage FormEmulsion for injection/infusion
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/055/004

Group Information

ATC CodeN01AX Other general anesthetics
N01AX10 propofol

Status

License statusAuthorised
Licence Issued02/11/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back